who discovered glp 1 agonists Scientists the Glucagon Yusa peptide (GLP-1) were selected as winners of the Lasker P Evolution of GLP‐1 Receptor Agonists

Clinical review of subcutaneous semaglutide for obesity

RELATED: New GLP-1 drugs could suppress desire for more than just food, study suggests Big picture view: The rapid rise in GLP-1 usage continues to align with broader improvements in national health, particularly aiding in lowering obesity rates

Thyroid Cancer In animal studies, GLP-1 medications caused thyroid tumors when given over a long period

Results: nejm.org/doi/full/10.10 #ADA2023

It is approved by the FDA for short-term use onlytypically 12 weeks or fewer

Long-term users of retatrutide who also exercise regularly and have lost significant weight may find their resting heart rate actually lower than pre-treatment levels, because the cardiovascular benefits of weight loss and improved fitness outweigh the modest pharmacological heart rate increase